Literature DB >> 7130973

beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.

V Glover, J Liebowitz, I Armando, M Sandler.   

Abstract

The inhibitory action of a range of beta-carbolines on human and rat monoamine oxidase (MAO) A and B has been studied. Concentrations of 5-hydroxytryptamine and phenylethylamine, approximately at their Km values, were used as substrates for MAO A and B respectively. A wide variation in selectivity was found, with harmaline being 10,000 times more potent an inhibitor of A than B whereas, using tetrahydro-beta-carboline and harmane, the difference was nearer to ten-fold. Of the carbolines which have been found endogenously, tetrahydro-beta-carboline, 6-methoxytetrahydro-beta-carboline and harmane are all sufficiently potent inhibitors of human MAO A, with I50 values of 5 X 10(-6), 10(-6), 5 X 10(-7) M respectively, for this property to be of possible physiological significance. Harmane, with an I50 of 5 X 10(-6) M, might also play a role as an inhibitor of MAO B.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130973     DOI: 10.1007/bf01254930

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  30 in total

1.  Distribution and inhibition characteristics of human brain monoamine oxidase.

Authors:  F Owen; A J Cross; R Lofthouse; V Glover
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

2.  Inhibitors of monoamine oxidase. Influence of methyl substitution on the inhibitory activity of beta-carbolines.

Authors:  B T Ho; W M McIsaac; K E Walker; V Estevez
Journal:  J Pharm Sci       Date:  1968-02       Impact factor: 3.534

3.  Inhibitors of monoamine oxidase. II. Syntheses of some N-2(9)-substituted tetrahydro-beta-carbolines and evaluation of their inhibitory activities.

Authors:  B T Ho; W M McIsaac; K E Walker
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

4.  Identification and quantification of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland.

Authors:  S A Barker; R E Harrison; J A Monti; G B Brown; S T Christian
Journal:  Biochem Pharmacol       Date:  1981-01-01       Impact factor: 5.858

5.  Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?

Authors:  R Lewinsohn; V Glover; M Sandler
Journal:  Biochem Pharmacol       Date:  1980-03-01       Impact factor: 5.858

6.  1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding.

Authors:  H Rommelspacher; C Nanz; H O Borbe; K J Fehske; W E Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

7.  Urinary MAO inhibitor in psychiatric illness.

Authors:  H Petursson; M A Reveley; V Glover; M Sandler
Journal:  Psychiatry Res       Date:  1981-12       Impact factor: 3.222

Review 8.  Beta-carbolines, psychoactive compounds in the mammalian body. Part I: Occurrence, origin and metabolism.

Authors:  M M Airaksinen; I Kari
Journal:  Med Biol       Date:  1981-02

9.  Identification by selective ion monitoring of 1-methyl-1,2,3,4-tetrahydro-beta-carboline in human platelets and plasma after ethanol intake.

Authors:  P Peura; I Kari; M M Airaksinen
Journal:  Biomed Mass Spectrom       Date:  1980-11

Review 10.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

View more
  9 in total

1.  Equol and other compounds from bovine urine as monoamine oxidase inhibitors.

Authors:  D Dewar; V Glover; J Elsworth; M Sandler
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Red wine contains a potent inhibitor of phenolsulphotransferase.

Authors:  J T Littlewood; V Glover; M Sandler
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

3.  Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.

Authors:  A Prasad; V Glover; B L Goodwin; M Sandler; M Signy; S E Smith
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding.

Authors:  J D Elsworth; D Dewar; V Glover; B L Goodwin; A Clow; M Sandler
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Effects of GABAA receptor ligands on noradrenaline concentration and beta-adrenoceptor binding in mouse cerebral cortex.

Authors:  D Gettins; N Goldsack; V Ibegbuna; S C Stanford
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 6.  Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.

Authors:  Narayan D Chaurasiya; Francisco Leon; Ilias Muhammad; Babu L Tekwani
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

7.  Inhibition of rat brain monoamine oxidase type A by 2-aminotetralin and tetrahydroisoquinoline analogues of dopamine.

Authors:  M G Feenstra; T van der Velden; D Dijkstra; O R Hommes; A S Horn
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

8.  Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Authors:  Adam L Halberstadt; Mahalah R Buell; Virginia L Masten; Victoria B Risbrough; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2008-07-08       Impact factor: 4.530

9.  Algicidal Activity of Streptomyces eurocidicus JXJ-0089 Metabolites and Their Effects on Microcystis Physiology.

Authors:  Bing-Huo Zhang; Zhang-Gui Ding; Han-Quan Li; Xiao-Zhen Mou; Yu-Qin Zhang; Jian-Yuan Yang; En-Min Zhou; Wen-Jun Li
Journal:  Appl Environ Microbiol       Date:  2016-08-15       Impact factor: 4.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.